- 2024-02-17 18:32Spiromesifen
- 2024-02-17 18:32LSD1-IN-30
- 2024-02-17 18:32LPA receptor antagonist-1
- 2024-02-17 18:32Antiviral agent 45
- 2024-02-17 18:32BATCP
- 2024-02-17 18:31Ulevostinag (isomer 2)
- 2024-02-17 18:31CF3–K11
- 2024-02-17 18:31WDR5-IN-7
- 2024-02-17 18:31Spirogermanium
- 2024-02-17 18:31Zharp1-211
- 2024-02-17 18:31BHEPN
- 2024-02-17 18:31CSF1R-IN-18
- 2024-02-17 18:31ZB-R-55
- 2024-02-17 18:31(S,R,S)-MI-1061
- 2024-02-17 18:31ET516
- 2024-02-17 18:31DiSulfo-ICG hydrazide
- 2024-02-17 18:31Antiproliferative agent-46
- 2024-02-17 18:31Glucobrassicin potassium
- 2024-02-17 18:30AEP-IN-3
- 2024-02-17 18:30HIV-IN-10
